Three SNP associations, rs599839 on 1p13.3 (SORT1-CELSR2-PSRC1), rs4977574 on 9p21 (CDKN2BAS1), and rs4775049 on 15q21–23 (LIPC), had P < 0.1 in the same direction of association in a separate New Zealand validation cohort (1,766 controls and 713 AAA cases) and were followed up in another separate cohort, the Wellcome Trust Case Control Consortium (WTCCC) AAA cohort (5,605 controls and 1,286 AAA cases). The gene discussed is LIPC; the disease is triple-A syndrome.